218 reports of this reaction
2.6% of all LOXAPINE reports
#3 most reported adverse reaction
TOXICITY TO VARIOUS AGENTS is the #3 most commonly reported adverse reaction for LOXAPINE, manufactured by Actavis Pharma, Inc.. There are 218 FDA adverse event reports linking LOXAPINE to TOXICITY TO VARIOUS AGENTS. This represents approximately 2.6% of all 8,319 adverse event reports for this drug.
Patients taking LOXAPINE who experience toxicity to various agents should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TOXICITY TO VARIOUS AGENTS is a less commonly reported adverse event for LOXAPINE, but still significant enough to appear in the safety profile.
In addition to toxicity to various agents, the following adverse reactions have been reported for LOXAPINE:
The following drugs have also been linked to toxicity to various agents in FDA adverse event reports:
TOXICITY TO VARIOUS AGENTS has been reported as an adverse event in 218 FDA reports for LOXAPINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
TOXICITY TO VARIOUS AGENTS accounts for approximately 2.6% of all adverse event reports for LOXAPINE, making it one of the most commonly reported side effect.
If you experience toxicity to various agents while taking LOXAPINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.